Enter your terms above and click the 'Search' button.

Showing articles 0 to 13 of 13 Filter Applied: melanoma,malignant (Click to remove) In Patients with Melanoma Brain Metastases, is Combination Immune Checkpoint Inhibition a Safe and Effective First-Line Treatment? A Critically Appraised Topic Neurologist 27:290-297, Gritsch, D.,et al, 2022 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016 Leptomeningeal Metastases in the MRI Era Neurol 74:1449-1454, Clarke,J.L., et al, 2010 A Diagnostic Approach to Multiple Simultaneous Intracerebral Hemorrhages Neurocrit Care 4:267-271, Finelli,P.F., 2006 Brain Metastases The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004 Neurology and the Skin JNNP 66:417-430, Hurko,O.&Provost,T.T., 1999 Intracranial Metastatic Melanoma:Correlation Between MR Imaging Characteristics and Melanin Content AJR 165:1503-1512, Isiklar,I.,et al, 1995 Intracranial Metastatic Melanoma:Correlation Between MR Imaging Characteristics and Melanin Content AJR 165:1503-1512, Isiklar,I.,et al, 1995 Meningeal Carcinomatosis Arch Neurol 38:696-699, Theodore,W.H.,et al, 1981 Computed Tomography in Metastatic Disease of the Brain Radiology 119:115-120, Deck,M.D.F.,et al, 1976 Infiltration of the Leptomeninges by Systemic Cancer:a Clinical & Pathologic Study Arch Neurol 30:122, Olson,M.E.,et al, 1974 Showing articles 0 to 13 of 13